OP Flashcards

1
Q

What is OP

A

Skeletal disorder, loss of bone mass and deterioration of bone tissue, increase in bone fragility and porous bones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most common OP fractures

A

Hip, wrist and spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

OP symptoms

A

Increases risk of fractures
Won’t have pain (if so it’s something else)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

OP risk factors

A

Woman
Age
Repeated steroid use
Underweight
Early menopause
Lifestyle ( alcohol, smoking , immobility)
Inflammatory conditions
Eating disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis of OP

A

FRAX to calculate fracture risk
Z and T scores
T score -1 to -2.5 osteopenia
T score less than -2.5 osteoporosis

DEXA scan
bone mineral density test (BMD) every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of OP

A

1st line alendronic acid /risedronate
Zoledronic (parental BP)
Denosumab (SB injection)
Teriparatide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs that increase risk of osteoporosis

A

Corticosteroids
PPI
Anti epileptics
Anti depressants (SSRI)
Cancer drugs (aromatase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lifestyle advice for OP

A

Stop smoking
Alcohol (14 units weekly)
Healthy weight
Exersize
Calcium and vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the interaction between calcium sups and oral BP

A

Reduce clinical effects of alendronic acid / risedroanate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Denosumab MOA

A

Mab that binds to RANKL, decreasing osteoclast formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Teriparatide MOA

A

Synthetic PTH with a biphasic effect and when given it activates osteoblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Raloxifene MOA

A

In the bone environment it acts as an ER agnosist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What directly activates osteoclasts

A

RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What modification prevents GI hydrolysis

A

Central oxygen is replaced with a carbon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is kyphosis

A

Visible postural change with an exaggerated posterior curve or rounding of the spine and lower back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is paget disease

A

Progressive skeletal disorder, excessive bone destruction and repair increasing structural changes of the long bones, spine, pelvis and cranium

17
Q

What are osteoblast cells in the bone

A

Active bone forming cells that produce collagenase bone matrix
Secretes enzyme alkaline phosphates
Promotes deposition of calcium phosphate salts in the matrix to calcify bones

18
Q

What are osteocytes cells in the bone

A

Osteoblasts become incorporated within the bone and transform into mature bone cells called osteocytes

19
Q

What are osteoclasts cells in the bone

A

Bone reabsorption
Remove bone matrix by phagocytosis, dissolve the bone salts and release calcium and phosphate ions in circulation
RANKL activates osteoclasts

20
Q

Which is only OP drug causes HYPERglacemia

A

Teriparatide

21
Q

What are alendronic/risedronate, Zoledronic and Denosumab monitoring

A

Oral BP - review 5 years continue or drug holiday for 1-2 years (long term risks ATF ONJ)

Zoledronic - review 3 years drug holiday, renal function, correct calcium and vitamin D before infusion

Denosumab - NO drug holiday (not retained in bone) renal and correct calcium and vit D before Injections

22
Q

What are the SERIOUS SE

A

REPORT any thigh/hip/groin pain - atypical fracture

Maintain good oral hygiene (ONJ)

23
Q

What are CI and cautions for alendronic and risedronate

A

Alendronic - AVOID eGFR below 35ml/min

Risedronate - AVOID eGFR below 30ml/min

Known hypoglycaemia
Swallowing difficulty / dysphasia
Recent GI bleed
Calcium ( take 2-4 hrs after )

24
Q

What to do if 1st line if c/I

A

If renal impairment (eGFR) use Denosumab as not renally cleared BUT higher hypoglycaemia risk